Europe Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Country and Growth Forecast, 2022 - 2028

Europe Ocular Trauma Devices Market Size, Share & Industry Trends Analysis Report By End-Use, By Type (Implants, Instruments, and Disposables), By Indication (Blunt Trauma, Chemical Trauma, and Sharp Trauma), By Country and Growth Forecast, 2022 - 2028

The Europe Ocular Trauma Devices Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028).

The iris' microvasculatures are generally harmed when there is a hyphema. In such cases, maintaining an upright posture, Eye protection, and prompt ophthalmologist referral are all part of the initial therapy. Additionally, in prominent cases of ocular trauma, a common symptom of vitreous hemorrhage is an acute vision which happens as a result of fundus opacification.

The risk of vitreous bleeding following trauma is increased by preexisting retinopathy in the presence of sickle cell disease or diabetes. After a retinal break, the neurosensory retina may subsequently separate from the surrounding retinal pigment epithelium, leading to a rhegmatogenous retinal detachment. In such instances, in order to maintain vision, surgery must be performed right away.

Corneal abrasions are defined as superficial wounds that can range in size from minor epithelial imperfections that heal on their own to visually noticeable lesions that progress to scarring, infection, and/or astigmatism. On the other hand, corneal incisions are a form of open globe injury that needs immediate surgical treatment. Pupil peaking, iris clogging, and anterior chamber flattening are frequently present in patients with corneal lacerations.

In Europe, vision loss affects one in thirty persons on average, and the number of partially sighted people outnumbers the number of blind people by a ratio of four. According to the European Blind Organization (EBU), vision loss affects one in three seniors over the age of 65. According to EBU estimates, there are 30 million visually impaired people in the region. Similarly, through a one-year study on patients in Western Infirmary Casualty Department and Glasgow Eye Infirmary, it was found that about 69.9% of eye injuries usually occurred at work.

The Germany market dominated the Europe Ocular Trauma Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $355.6 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.7% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.3% during (2022 - 2028).

Based on End-Use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on Type, the market is segmented into Implants, Instruments, and Disposables. Based on Indication, the market is segmented into Blunt Trauma, Chemical Trauma, and Sharp Trauma. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.

Scope of the Study

Market Segments covered in the Report:

By End-Use

  • Hospitals
  • Ophthalmic Clinics
  • Others
By Type
  • Implants
  • Instruments
  • Disposables
By Indication
  • Blunt Trauma
  • Chemical Trauma
  • Sharp Trauma
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
  • Glaukos Corporation
  • Alcon, Inc.
  • EssilorLuxottica SA (Essilor Instruments USA)
  • Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
  • Carl Zeiss AG
  • Topcon Corporation
  • CooperVision, Inc. (THE COOPER COMPANIES, INC.)
  • Hoya Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Ocular Trauma Devices Market, by End-Use
1.4.2 Europe Ocular Trauma Devices Market, by Type
1.4.3 Europe Ocular Trauma Devices Market, by Indication
1.4.4 Europe Ocular Trauma Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Ocular Trauma Devices Market by End-Use
3.1 Europe Hospitals Market by Country
3.2 Europe Ophthalmic Clinics Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Ocular Trauma Devices Market by Type
4.1 Europe Implants Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Disposables Market by Country
Chapter 5. Europe Ocular Trauma Devices Market by Indication
5.1 Europe Blunt Trauma Market by Country
5.2 Europe Chemical Trauma Market by Country
5.3 Europe Sharp Trauma Market by Country
Chapter 6. Europe Ocular Trauma Devices Market by Country
6.1 Germany Ocular Trauma Devices Market
6.1.1 Germany Ocular Trauma Devices Market by End-Use
6.1.2 Germany Ocular Trauma Devices Market by Type
6.1.3 Germany Ocular Trauma Devices Market by Indication
6.2 UK Ocular Trauma Devices Market
6.2.1 UK Ocular Trauma Devices Market by End-Use
6.2.2 UK Ocular Trauma Devices Market by Type
6.2.3 UK Ocular Trauma Devices Market by Indication
6.3 France Ocular Trauma Devices Market
6.3.1 France Ocular Trauma Devices Market by End-Use
6.3.2 France Ocular Trauma Devices Market by Type
6.3.3 France Ocular Trauma Devices Market by Indication
6.4 Russia Ocular Trauma Devices Market
6.4.1 Russia Ocular Trauma Devices Market by End-Use
6.4.2 Russia Ocular Trauma Devices Market by Type
6.4.3 Russia Ocular Trauma Devices Market by Indication
6.5 Spain Ocular Trauma Devices Market
6.5.1 Spain Ocular Trauma Devices Market by End-Use
6.5.2 Spain Ocular Trauma Devices Market by Type
6.5.3 Spain Ocular Trauma Devices Market by Indication
6.6 Italy Ocular Trauma Devices Market
6.6.1 Italy Ocular Trauma Devices Market by End-Use
6.6.2 Italy Ocular Trauma Devices Market by Type
6.6.3 Italy Ocular Trauma Devices Market by Indication
6.7 Rest of Europe Ocular Trauma Devices Market
6.7.1 Rest of Europe Ocular Trauma Devices Market by End-Use
6.7.2 Rest of Europe Ocular Trauma Devices Market by Type
6.7.3 Rest of Europe Ocular Trauma Devices Market by Indication
Chapter 7. Company Profiles
7.1 Johnson & Johnson (Johnson & Johnson Vision Care, Inc.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals and Trials:
7.1.6 SWOT Analysis
7.2 Glaukos Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Alcon, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals and Trials:
7.3.5.2 Acquisition and Mergers:
7.4 EssilorLuxottica SA (Essilor Instruments USA)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bausch + Lomb Corporation (Bausch Health Companies, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Carl Zeiss AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Topcon Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 CooperVision, Inc. (THE COOPER COMPANIES, INC.)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Hoya Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings